Kei Takamura

Obihiro, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, Japan.

Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, Japan.

Journal: Auris, nasus, larynx

Published: February 11, 2026

Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study.

Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study.

Journal: International journal of clinical oncology

Published: May 03, 2025

Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.

Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.

Journal: Respiratory medicine

Published: April 23, 2025

Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).

Journal: Neuro-oncology advances

Published: November 14, 2024

Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Journal: Cancer research communications

Published: April 08, 2024

Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer.

Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 26, 2024

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2023

Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.

Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.

Journal: Cancer medicine

Published: January 15, 2023

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 06, 2022

Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.

Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.

Journal: International journal of clinical oncology

Published: September 30, 2021

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer.

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer.

Journal: Oncoimmunology

Published: September 23, 2021

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults.

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults.

Journal: Journal of rural medicine : JRM

Published: July 19, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026